Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on Therapy

Clinical trial NCT00857584 · COMPLETED

Trial details

NCT number: NCT00857584
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Disorder Bipolar Depression

Start date: 2009-05-01
Primary completion: 2011-02-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.